Twist Bioscience Corporation (NASDAQ: TWST) is a Healthcare company (Biotechnology) with a market capitalization of $7.4B. The Maz Rating grades it against the other companies in its sector.
Twist Bioscience Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $112.00, Twist Bioscience Corporation trades at 15.9x sales and 7.8x book value. Over the last twelve months it generated about $465M of revenue and a net loss of $139M. It runs a gross margin of 52.4%, an operating margin of -30.4% and a net margin of -28.3%. It shows return on equity of -23.2%, return on invested capital of -13.8% and a free cash flow yield of -1.2%. On the balance sheet: a debt-to-equity ratio of 0.11 and a current ratio of 5.86. Over the past 52 weeks the share price ranged from $24.41 to $219.71, with a beta of 2.22.
Twist Bioscience Corporation does not currently pay a dividend.
15 Wall Street analyst ratings cover the stock: 11 Buy, 2 Hold and 2 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.